According to Gram Research analysis, certain gut bacteria produce an enzyme that breaks down vitamin D into an inactive form, and this process may contribute to depression. A 2026 study found that E. coli bacteria from depressed patients with low vitamin D could metabolize vitamin D in laboratory tests, and when given to mice, these bacteria reduced blood vitamin D levels and triggered depression-like behaviors. The enzyme responsible, called a sulfotransferase, was significantly more abundant in depressed patients compared to healthy controls, suggesting this bacterial process may play a role in depression development.

Researchers discovered that certain bacteria in the digestive system of people with depression may be breaking down vitamin D in a way that makes depression worse. Scientists found that a common gut bacterium called E. coli produces an enzyme that transforms vitamin D into a form that cannot be used by the body. When this bacterium was given to mice, it lowered their vitamin D levels and caused depression-like behaviors. The study suggests that this bacterial process might explain why some people with depression also have low vitamin D, opening new possibilities for understanding and treating depression through gut health.

Key Statistics

A 2026 study published in Brain, Behavior, and Immunity found that E. coli bacteria isolated from depressed patients with vitamin D deficiency produced an enzyme capable of breaking down active vitamin D into an inactive form in laboratory tests.

Mice given E. coli bacteria from depressed patients showed both reduced blood vitamin D levels and depression-like behaviors, suggesting a direct link between this bacterial process and depressive symptoms.

Depressed patients with vitamin D deficiency had significantly higher prevalence of E. coli bacteria and greater abundance of the vitamin D-metabolizing enzyme gene compared to healthy control subjects.

When mice were given the sulfated form of vitamin D (the product created when bacteria break down vitamin D), they displayed depression-like behaviors, indicating the transformed vitamin D itself may contribute to depression.

The Quick Take

  • What they studied: Whether certain gut bacteria can break down vitamin D and whether this process contributes to depression
  • Who participated: Depressed patients with low vitamin D (for bacterial samples), healthy control subjects, and laboratory mice used to test the effects of the bacteria
  • Key finding: A specific gut bacterium produces an enzyme that converts active vitamin D into an inactive form, and this process appears to trigger depression-like symptoms in mice
  • What it means for you: If confirmed in humans, this research suggests that managing gut bacteria health might help prevent or reduce depression in people with vitamin D deficiency. However, this is early-stage research and should not replace current depression treatments

The Research Details

Researchers collected bacteria from the stool samples of people with depression and low vitamin D levels. They grew these bacteria in the laboratory and tested whether they could break down vitamin D. They identified the specific enzyme responsible for this breakdown, which is called a sulfotransferase. To test whether this process actually causes depression, scientists gave the bacteria to mice through oral gavage (a feeding tube). They measured vitamin D levels in the mice’s blood and observed their behavior to see if they showed signs of depression. The team also created genetically engineered bacteria that produced extra amounts of the vitamin D-breaking enzyme to see if this made the effect stronger. Finally, they compared the amount of this enzyme-producing bacteria in depressed patients versus healthy people.

This research approach is important because it bridges the gap between observation and mechanism. Scientists had noticed that depression and low vitamin D often occur together, but they did not know why. By isolating the actual bacteria and testing them in living animals, researchers could demonstrate a direct cause-and-effect relationship. This type of evidence is much stronger than simply noticing that two conditions happen at the same time.

The study used multiple approaches to confirm findings: testing bacteria in test tubes, testing in living mice, identifying the specific gene responsible, and comparing patient samples to healthy controls. This strengthens confidence in the results. However, the research was conducted in mice, not humans, so results may not directly apply to people. The study also did not specify the exact number of patient samples analyzed, which makes it harder to assess how representative the findings are

What the Results Show

When E. coli bacteria from depressed patients were given to mice, the mice’s blood vitamin D levels dropped significantly. These mice also displayed depression-like behaviors, such as reduced activity and changes in how they responded to stress. When researchers created bacteria with extra copies of the vitamin D-breaking enzyme, the effect was even stronger, suggesting that the amount of enzyme produced matters. The enzyme works by adding a sulfate group to vitamin D, transforming it into a compound called 25[OH]D3-3-sulfate. Interestingly, when researchers gave mice this sulfated form of vitamin D directly, it also caused depression-like behaviors, suggesting that the transformed vitamin D itself may be harmful.

The study found that depressed patients with low vitamin D had significantly more of this bacteria and more copies of the vitamin D-breaking enzyme gene compared to healthy people. This suggests that the bacterial process is not just a laboratory curiosity but may actually be present and active in people with depression. The consistency of these findings across multiple experimental approaches strengthens the evidence that this mechanism is real

Previous research has shown that low vitamin D is associated with depression, but the reason for this connection was unclear. Some scientists thought vitamin D deficiency directly caused depression through effects on the brain. This study suggests an alternative explanation: certain gut bacteria may be causing the vitamin D deficiency in the first place, which then contributes to depression. This finding adds a new layer of understanding to the vitamin D-depression connection and suggests that gut bacteria may play a previously unrecognized role

The most important limitation is that this research was conducted in mice, not humans. Mice brains and digestive systems work differently from human brains and digestive systems, so results may not translate directly. The study did not measure vitamin D levels or depression symptoms in the same human patients, only compared bacterial samples between groups. The exact number of patient samples analyzed was not specified, making it unclear how well the findings represent all depressed people. The study also did not test whether treating or removing these bacteria would actually improve depression in any living subjects

The Bottom Line

This research is too early-stage to recommend specific actions for individuals. If you have depression and low vitamin D, continue following your doctor’s treatment plan. Vitamin D supplementation remains a reasonable approach for people with documented deficiency, though this study suggests the underlying problem may be more complex. Future research may eventually lead to treatments targeting gut bacteria, but such treatments do not yet exist. Confidence level: Low to Moderate, as this is preliminary research requiring human studies

People with depression and low vitamin D should be aware of this research as it may eventually lead to new treatment options. Healthcare providers treating depression should monitor this research area. People interested in gut health and mental health connections will find this relevant. This research should not change current treatment decisions until human studies confirm the findings

This is fundamental research that explains a potential mechanism. Translating these findings into actual treatments for humans will likely take 5 to 10 years or more. Any new treatments would need to be tested in clinical trials before becoming available to patients

Frequently Asked Questions

Can gut bacteria actually cause depression by breaking down vitamin D?

Research shows that certain gut bacteria produce an enzyme that breaks down vitamin D, and this process triggered depression-like symptoms in mice. However, this has only been demonstrated in animals so far. Human studies are needed to confirm whether this bacterial process actually causes depression in people

Should I take vitamin D supplements if I have depression?

If your doctor has diagnosed you with vitamin D deficiency, supplementation remains appropriate. This research suggests the underlying problem may be more complex than previously thought, but it does not change current treatment recommendations. Discuss vitamin D testing and supplementation with your healthcare provider

Does this mean probiotics could help treat depression?

Not necessarily. While this research identifies a harmful bacterial process, it does not prove that probiotics or other gut bacteria treatments would help. In fact, adding bacteria without understanding which strains are beneficial could be risky. Wait for human clinical trials before considering bacteria-based depression treatments

How long until this research leads to new depression treatments?

This is early-stage research that explains a potential mechanism. Translating these findings into actual treatments for humans typically takes 5 to 10 years or longer, requiring multiple clinical trials. Current depression treatments remain the evidence-based standard of care

What should I do if I have both depression and low vitamin D?

Continue working with your healthcare provider on your current depression treatment plan. If vitamin D deficiency is confirmed through testing, supplementation is reasonable. This research may eventually lead to new approaches, but should not change your current medical care

Want to Apply This Research?

  • Track weekly vitamin D levels (if testing is available), mood scores on a 1-10 scale, and digestive health indicators such as bloating or changes in bowel habits. Note any correlations between these measurements over time
  • Users could log their vitamin D supplementation, dietary sources of vitamin D, and probiotic intake alongside mood tracking. This creates awareness of potential connections between gut health and mental health while supporting existing depression management strategies
  • Establish a baseline of current vitamin D levels and mood. Monitor these monthly while maintaining current treatments. If future research supports gut-targeted interventions, users can track how changes in gut bacteria composition correlate with mood and vitamin D status

This research is preliminary and has only been demonstrated in laboratory and animal studies. It has not been confirmed in human clinical trials. This information should not be used to replace professional medical advice, diagnosis, or treatment. If you have depression or vitamin D deficiency, consult with a qualified healthcare provider before making any changes to your treatment plan. Do not start, stop, or modify any medications or supplements without medical supervision. This article describes research findings and does not constitute medical advice

This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.

Source: Gut microbiota-expressed sulfotransferase sulfonates 25-hydroxyvitamin D3 and promotes depression. , Brain, behavior, and immunity (2026). PubMed 42833523 | DOI
Topics
gut bacteria depression vitamin D deficiency E. coli sulfotransferase microbiota mental health vitamin D metabolism depression treatment gut health bacterial enzyme